311 related articles for article (PubMed ID: 28740387)
1. Apatinib-loaded nanoparticles suppress vascular endothelial growth factor-induced angiogenesis and experimental corneal neovascularization.
Lee JE; Kim KL; Kim D; Yeo Y; Han H; Kim MG; Kim SH; Kim H; Jeong JH; Suh W
Int J Nanomedicine; 2017; 12():4813-4822. PubMed ID: 28740387
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic effect of apatinib-loaded nanoparticles on diabetes-induced retinal vascular leakage.
Jeong JH; Nguyen HK; Lee JE; Suh W
Int J Nanomedicine; 2016; 11():3101-9. PubMed ID: 27462154
[TBL] [Abstract][Full Text] [Related]
3. Utilization of Apatinib-Loaded Nanoparticles for the Treatment of Ocular Neovascularization.
Halasz K; Kelly SJ; Iqbal MT; Pathak Y; Sutariya V
Curr Drug Deliv; 2019; 16(2):153-163. PubMed ID: 30332959
[TBL] [Abstract][Full Text] [Related]
4. Apatinib, an Inhibitor of Vascular Endothelial Growth Factor Receptor 2, Suppresses Pathologic Ocular Neovascularization in Mice.
Kim KL; Suh W
Invest Ophthalmol Vis Sci; 2017 Jul; 58(9):3592-3599. PubMed ID: 28715845
[TBL] [Abstract][Full Text] [Related]
5. Emodin suppresses alkali burn-induced corneal inflammation and neovascularization by the vascular endothelial growth factor receptor 2 signaling pathway.
Xueying Z; Liang G; Siyi L; Fengyue LI; Mingli L; Wanting L; Chun M; Guanghui L
J Tradit Chin Med; 2024 Apr; 44(2):268-276. PubMed ID: 38504533
[TBL] [Abstract][Full Text] [Related]
6. Celastrol nanoparticles inhibit corneal neovascularization induced by suturing in rats.
Li Z; Yao L; Li J; Zhang W; Wu X; Liu Y; Lin M; Su W; Li Y; Liang D
Int J Nanomedicine; 2012; 7():1163-73. PubMed ID: 22419865
[TBL] [Abstract][Full Text] [Related]
7. Xanthatin inhibits corneal neovascularization by inhibiting the VEGFR2‑mediated STAT3/PI3K/Akt signaling pathway.
Shen M; Zhou XZ; Ye L; Yuan Q; Shi C; Zhu PW; Jiang N; Ma MY; Yang QC; Shao Y
Int J Mol Med; 2018 Aug; 42(2):769-778. PubMed ID: 29717775
[TBL] [Abstract][Full Text] [Related]
8. A Novel Peptide Derived From Tissue-Type Plasminogen Activator Potently Inhibits Angiogenesis and Corneal Neovascularization.
Kim HK; Choi JS; Lee SW; Joo CK; Joe YA
J Cell Biochem; 2017 May; 118(5):1132-1143. PubMed ID: 27618679
[TBL] [Abstract][Full Text] [Related]
9. Imidazole-based alkaloid derivative LCB54-0009 suppresses ocular angiogenesis and lymphangiogenesis in models of experimental retinopathy and corneal neovascularization.
Kim BH; Lee J; Choi JS; Park DY; Song HY; Park TK; Cho CH; Ye SK; Joo CK; Koh GY; Kim TY
Br J Pharmacol; 2015 Aug; 172(15):3875-89. PubMed ID: 25917462
[TBL] [Abstract][Full Text] [Related]
10. Apatinib-loaded nanoparticles inhibit tumor growth and angiogenesis in a model of melanoma.
Zhang J; Liu P; Zhang Z; Han J; Yang X; Wang A; Zhang X
Biochem Biophys Res Commun; 2020 Jan; 521(2):296-302. PubMed ID: 31668370
[TBL] [Abstract][Full Text] [Related]
11. Curcumin nanoparticles inhibit corneal neovascularization.
Pradhan N; Guha R; Chowdhury S; Nandi S; Konar A; Hazra S
J Mol Med (Berl); 2015 Oct; 93(10):1095-106. PubMed ID: 25877858
[TBL] [Abstract][Full Text] [Related]
12. Nanoparticle-mediated expression of a Wnt pathway inhibitor ameliorates ocular neovascularization.
Wang Z; Cheng R; Lee K; Tyagi P; Ding L; Kompella UB; Chen J; Xu X; Ma JX
Arterioscler Thromb Vasc Biol; 2015 Apr; 35(4):855-64. PubMed ID: 25657312
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic effects of a novel PIGF-1 derived peptide, ZY-1, on corneal neovascularization in vitro and in vivo.
Lu Y; Zheng Y; Ai J; Xu X
Discov Med; 2016 May; 21(117):349-61. PubMed ID: 27355331
[TBL] [Abstract][Full Text] [Related]
14. In vivo effect of bevacizumab-loaded albumin nanoparticles in the treatment of corneal neovascularization.
Luis de Redín I; Boiero C; Recalde S; Agüeros M; Allemandi D; Llabot JM; García-Layana A; Irache JM
Exp Eye Res; 2019 Aug; 185():107697. PubMed ID: 31228461
[TBL] [Abstract][Full Text] [Related]
15. Nanoparticle-mediated endothelial cell-selective delivery of pitavastatin induces functional collateral arteries (therapeutic arteriogenesis) in a rabbit model of chronic hind limb ischemia.
Oda S; Nagahama R; Nakano K; Matoba T; Kubo M; Sunagawa K; Tominaga R; Egashira K
J Vasc Surg; 2010 Aug; 52(2):412-20. PubMed ID: 20573471
[TBL] [Abstract][Full Text] [Related]
16. Inhibitory effects of bevacizumab on angiogenesis and corneal neovascularization.
Han YS; Lee JE; Jung JW; Lee JS
Graefes Arch Clin Exp Ophthalmol; 2009 Apr; 247(4):541-8. PubMed ID: 18953554
[TBL] [Abstract][Full Text] [Related]
17. Inhibitory effect of curcumin on corneal neovascularization in vitro and in vivo.
Bian F; Zhang MC; Zhu Y
Ophthalmologica; 2008; 222(3):178-86. PubMed ID: 18497527
[TBL] [Abstract][Full Text] [Related]
18. Forkhead Domain Inhibitor-6 Suppresses Corneal Neovascularization and Subsequent Fibrosis After Alkali Burn in Rats.
Lan C; Liu G; Huang L; Wang X; Tan J; Wang Y; Fan N; Zhu Y; Yu M; Liu X
Invest Ophthalmol Vis Sci; 2022 Apr; 63(4):14. PubMed ID: 35446346
[TBL] [Abstract][Full Text] [Related]
19. Ginsenoside Rh2 inhibits vascular endothelial growth factor-induced corneal neovascularization.
Zhang XP; Li KR; Yu Q; Yao MD; Ge HM; Li XM; Jiang Q; Yao J; Cao C
FASEB J; 2018 Jul; 32(7):3782-3791. PubMed ID: 29465315
[TBL] [Abstract][Full Text] [Related]
20. Preparation of arginine-glycine-aspartic acid-modified biopolymeric nanoparticles containing epigalloccatechin-3-gallate for targeting vascular endothelial cells to inhibit corneal neovascularization.
Chang CY; Wang MC; Miyagawa T; Chen ZY; Lin FH; Chen KH; Liu GS; Tseng CL
Int J Nanomedicine; 2017; 12():279-294. PubMed ID: 28115846
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
